Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Biomol Struct Dyn ; 40(16): 7283-7302, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-33719908

RESUMO

Lassa mammarenavirus (LASMV) is responsible for a specific type of acute viral hemorrhagic fever known as Lassa fever. Lack of effective treatments and counter-measures against the virus has resulted in a high mortality rate in its endemic regions. Therefore, in this study, a novel epitope-based vaccine has been designed using the methods of immunoinformatics targeting the glycoprotein and nucleoprotein of the virus. After numerous robust analyses, two CTL epitopes, eight HTL epitopes and seven B-cell epitopes were finally selected for constructing the vaccine. All these most promising epitopes were found to be antigenic, non-allergenic, nontoxic and non-human homolog, which made them suitable for designing the subunit vaccine. Furthermore, the selected T-cell epitopes which were found to be fully conserved across different isolates of the virus, were also considered for final vaccine construction. After that, numerous validation experiments, i.e. molecular docking, molecular dynamics simulation and immune simulation were conducted, which predicted that our designed vaccine should be stable within the biological environment and effective in combating the LASMV infection. In the end, codon adaptation and in silico cloning studies were performed to design a recombinant plasmid for producing the vaccine industrially. However, further in vitro and in vivo assessments should be done on the constructed vaccine to finally confirm its safety and efficacy.Communicated by Ramaswamy H. Sarma.


Assuntos
Arenaviridae , Nucleoproteínas , Arenaviridae/genética , Epitopos de Linfócito B , Epitopos de Linfócito T , Glicoproteínas , Simulação de Acoplamento Molecular , Nigéria , Nucleoproteínas/genética , Vacinas de Subunidades Antigênicas
2.
Am J Trop Med Hyg ; 104(1): 30-31, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33236705

RESUMO

The WHO recently expressed concern at the potential impact of COVID-19 on hunger, which is likely to exacerbate the already considerable burden of malnutrition of Africa. The impact of the disease is expected to be greater among those grappling with malnutrition, whereas widespread hunger and malnutrition will likely increase because of movement restrictions. COVID-19 is unfolding in Africa against a backdrop of worrying levels of hunger and undernourishment which could worsen as the virus threatens livelihoods and household economies. The perspective piece addresses the crisis within crisis of COVID-19 and hunger on the well-being of children in Africa.


Assuntos
COVID-19/epidemiologia , Transtornos da Nutrição Infantil , Abastecimento de Alimentos , Fome , África/epidemiologia , Criança , Países em Desenvolvimento , Humanos , Pobreza , SARS-CoV-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA